Home
Search
Agriculture & Environment

Addressing Climate Change

There are more than 5 trillion pieces of plastic floating in our oceans. The U.S. transportation sector leads all other sectors in greenhouse gas emissions. Diseases that thrive in hot weather are killing important staple crops. Our reliance on products derived from fossil fuels is harming our planet.

Climate change is real but through biotechnology, we can meet these challenges head-on by making the same reliable plastics, foods, and fuels with less environmental impact.

Dr Michelle Climate
Biotech Solutions for Climate Report
Biotech Solutions for Climate Executive Summary
More on BIO's Global Climate Leadership
Latest from BIO's Experts...
GMOS and Gene Editing—Nothing to Be Afraid Of
GMOS and Gene Editing—Nothing to Be Afraid Of
Learn more
Escaping the Food Allergy Prison
Escaping the Food Allergy Prison
Learn more
Car Free Day
Car-Free Day: Could Biotech Make It a Thing of the Past?
Learn more
Bananas
Improving Food Systems: The Case of the Banana
Learn more
roots Trees Alone Can’t Solve Our Climate Issues
Trees Alone Can’t Solve Our Climate Issues
Learn more
Press Releases
Browse all Press Releases
BIO Statement on PIPs Rule: EPA Misses Opportunity to Advance Food, Ag Innovation
May 25, 2023
The following statement concerning the Environmental Protection Agency’s final rule on regulation of Plant Incorporated Protectants (PIPs) under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) may be attributed to John Murphy, chief policy officer and deputy general counsel for the…
FDA Commissioner Dr. Robert Califf to Address Medical Misinformation During Keynote Address at BIO International Convention
May 25, 2023
BIO CEO Rachel King and Califf will discuss  issues impacting FDA and the biotech community WASHINGTON - (May 25, 2023) – Robert Califf, commissioner of the Food and Drug Administration, will be the keynote speaker on day three of the 2023 BIO International Convention. In a wide-ranging…
Katie Couric, Award-Winning Journalist and Health Advocate to Headline BIO International Convention
May 16, 2023
BIO CEO Rachel King and Couric to Discuss How Standing Up for Science and Patients Are at the Heart of Biotech WASHINGTON - (May 16, 2023) – Katie Couric, award-winning journalist, New York Times best-selling author, and longtime cancer advocate, will discuss her tireless pursuit to stand up…
Good Day BIO Newsletter
Subscribe to GoodDay BIO

Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics and policy. 

Subscribe

A Timeline of Modernizing Food and Farm Biotech Laws...

plants
2019: USDA Announces SECURE Rule

To provide transparency to consumers, BIO advocates for the agency to require developers to notify them when new plants are brought to market,

Cabinet
2019: Executive Order to Modernize Biotech Framework

President Trump directs USDA, EPA, and FDA to align existing biotech regulations with actual risk and to grow pubic confidence in biotech to benefit our food, health, and planet.

Trump Rural
2017: Trump Administration Establishes Rural Prosperity Task Force

The task force includes biotechnology as part of its recommendations to the government on how to strengthen rural economies.

Obama produce
2017: Obama Administration Updates Biotech Laws

To keep up with 21st-century innovations USDA and FDA begin updating definitions and enforcement of biotech plants and animals. 

obama flag
2012: National Bioeconomy Blueprint Unveiled

The blueprint is a comprehensive vision to strengthen America's economy through technology and science, and spotlights agricultural biotechnology.

Letters, Comments & Testimony
Browse all Letters, Comments & Testimony
BIO Comments to FDA (Docket No. FDA-2023-N-0398) on Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products
May 26, 2023
In these comments, BIO addresses FDA’s four specific topic areas of consideration as the agency develops its draft guidance per PDUFA VII.
Letter in support of U.S. Codex Office funding
May 30, 2023
BIO joined with more than 40 groups in calling on Congress to set 2024 funding for the U.S. Codex Office at or above the 2023 level. 
BIO Comments to the FDA on Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics (Docket No. FDA–2023-D-0110)
May 25, 2023
BIO’s comments support accelerated approval as an important regulatory pathway that allows patients with serious and life-threatening illnesses such as cancer to have earlier access to promising therapies.